STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Conformis, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Conformis, a leader in personalized orthopedic medical devices, announced that CEO Mark Augusti will present at the Oppenheimer MedTech Summit on May 26, 2021. A webcast of the virtual presentation will be available on the summit day. Additionally, Conformis management will host one-on-one meetings with attendees. For further inquiries or to schedule meetings, interested parties can contact Conformis Investor Relations. The presentation's replay will be accessible for 30 days on Conformis' website under the 'Events and Presentations' section.

Positive
  • None.
Negative
  • None.

BILLERICA, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, will present at the Oppenheimer MedTech, Tools & Diagnostics Summit.

A webcast of the virtual presentation will be made available on the day of the summit, Wednesday, May 26, 2021.

Conformis management will also be available for one-on-one meetings throughout the summit. For more information about the conference or to schedule a one-on-one meeting with management, please contact your Oppenheimer representative or Conformis Investor Relations at ir@conformis.com and (781) 374-5598.

The replay of the webcast of the presentation will be archived on Conformis' website for 30 days following the presentation under "Events and Presentations" in the Investors section of the Conformis website at ir.conformis.com.

About Conformis, Inc.

Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit and conform to each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

For more information, visit www.comformis.com. To receive future releases in e-mail alerts, sign up at ir.conformis.com.


FAQ

When will Conformis present at the Oppenheimer MedTech Summit?

Conformis will present at the Oppenheimer MedTech Summit on May 26, 2021.

Where can I watch the Conformis presentation?

The Conformis presentation will be available via webcast on the day of the summit.

How can I schedule a one-on-one meeting with Conformis management?

To schedule a meeting with Conformis management, contact your Oppenheimer representative or Conformis Investor Relations.

How long will the webcast replay of Conformis' presentation be available?

The replay of Conformis' presentation will be archived for 30 days after the event.

What technology does Conformis use for its orthopedic devices?

Conformis utilizes its proprietary iFit® Image-to-Implant® technology platform to create personalized implants.

Conformis, Inc.

NASDAQ:CFMS

CFMS Rankings

CFMS Latest News

CFMS Stock Data

17.88M
7.57M
6.29%
22.56%
1.06%
Medical Devices
Healthcare
Link
United States
Billerica